Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:56:57.410Z.
Calculation as of: 2026-10-06T14:56:57.410Z.
Quote observation: 2026-10-06T14:55:29.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$131.22M
Operating Cash Flow Yield
N/A
TTM Avg
1.70%
3Y Avg
1.70%
5Y Avg
1.70%
Market Cap
$135.17M
Operating Cash Flow Yield
N/A
TTM Avg
6.01%
3Y Avg
5.49%
5Y Avg
5.49%
Market Cap
$129.68M
Operating Cash Flow Yield
21.77%
TTM Avg
12.96%
3Y Avg
8.76%
5Y Avg
8.76%
Market Cap
$136.65M
Operating Cash Flow Yield
1.02%
TTM Avg
0.36%
3Y Avg
0.36%
5Y Avg
0.36%
Market Cap
$139.73M
Operating Cash Flow Yield
90.12%
TTM Avg
20.54%
3Y Avg
20.54%
5Y Avg
20.54%
Market Cap
$138.69M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$126.92M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$140.03M
Operating Cash Flow Yield
0.91%
TTM Avg
3.24%
3Y Avg
4.92%
5Y Avg
5.15%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Freenome, Inc. (FRNM) | $133.37M | N/A | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $131.22M | N/A | 1.70% | 1.70% | 1.70% |
| LifeMD, Inc. (LFMD)vs › | $135.17M | N/A | 6.01% | 5.49% | 5.49% |
| Health Catalyst, Inc. (HCAT)vs › | $129.68M | 21.77% | 12.96% | 8.76% | 8.76% |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.65M | 1.02% | 0.36% | 0.36% | 0.36% |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 90.12% | 20.54% | 20.54% | 20.54% |
| Alpha Cognition Inc (ACOG)vs › | $138.69M | N/A | N/A | N/A | N/A |
| Entera Bio Ltd. (ENTX)vs › | $126.92M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $140.03M | 0.91% | 3.24% | 4.92% | 5.15% |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $122.96M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
